1. Home
  2. WEST vs CSTL Comparison

WEST vs CSTL Comparison

Compare WEST & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westrock Coffee Company

WEST

Westrock Coffee Company

HOLD

Current Price

$9.85

Market Cap

812.3M

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$33.05

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEST
CSTL
Founded
2009
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
812.3M
722.8M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
WEST
CSTL
Price
$9.85
$33.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$10.00
★ $45.22
AVG Volume (30 Days)
★ 338.6K
319.5K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $1,188,952,000.00
$344,229,000.00
Revenue This Year
$3.92
$8.49
Revenue Next Year
$7.72
$10.44
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 39.76
3.66
52 Week Low
$3.59
$17.72
52 Week High
$10.19
$44.28

Technical Indicators

Market Signals
Indicator
WEST
CSTL
Relative Strength Index (RSI) 79.26 47.52
Support Level $7.66 $31.44
Resistance Level $10.00 $34.23
Average True Range (ATR) 0.38 1.69
MACD 0.17 -0.13
Stochastic Oscillator 94.82 21.52

Price Performance

Historical Comparison
WEST
CSTL

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider mainly in the United States. Additionally, it offers coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice, restaurant, convenience store, travel center, non-commercial account, and hospitality industries around the world. The company's reportable segments are: Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment, which offers beverage solutions, including coffee, tea, flavors, extracts, and ingredients. Geographically, the company generates maximum revenue from its business in the United States and the rest from other countries.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: